Ledger.Open graph →
SEC Form D · filed February 22, 2021

Silo Pharma, Inc

Offering
$4.3M
Sold
$4.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
ENGLEWOOD CLIFFS, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Eric Weisblum · Englewood Cliffs, NJExec · DirectorWayne D. Linsley · Englewood Cliffs, NJDirectorKevin D. Munoz · Englewood Cliffs, NJDirectorDavid Sung · Vancouver, British Columbia, CanadaDirectorRyan Metzger · Dover, DEExec · DirectorPraveen P. Tipirneni · Watertown, MADirectorAlise Reicin · Watertown, MAExec · DirectorKevin D. Munoz · Englewood Cliffs, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗